journal article·2026-05-30Open access

Explainable Machine Learning Prognosis of Coronary Artery Disease Using Lifestyle and Medical History Data

Agorastos-Dimitrios Samaras, Ioannis D. Apostolopoulos, Elpiniki Papageorgiou, Nikolaos Papandrianos

Applied Sciences· Volume 16· Issue 11

Abstract

Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide, emphasizing the need for early and scalable risk stratification approaches. While recent Machine Learning (ML) studies have reported high diagnostic performance using multimodal clinical, laboratory, imaging, and genetic data, they do not provide early screening or prognosis. In this study, we investigate the extent to which CAD prognosis can be achieved using lifestyle and medical history variables alone. We pooled a cohort of 571 participants with and without CAD and evaluated multiple ML models, including Random Forest, CatBoost, AdaBoost, XGBoost, TabPFN, and k-Nearest Neighbors, using 10-fold cross-validation. Across models, predictive performance converged in a narrow range (72–76% accuracy), with the best-performing models reaching approximately 76% accuracy, compared to a clinician baseline of 78.8%. To enhance transparency and clinical interpretability, we further outline an explainability analysis for the top-performing model using SHAP-based approaches. Overall, this work highlights both the potential and the limitations of lifestyle-based ML models for CAD prognosis and supports their role as complementary tools for early screening and preventive cardiology.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Artificial Intelligence in Healthcare · Cardiovascular Disease and Adiposity · Explainable Artificial Intelligence (XAI)

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Energy Systems, University of Thessaly, Gaiopolis Campus, 41500 Larisa, Greece

Artificial Intelligence, Computational Methods & Technological Applications (ACTA), University of Thessaly, Gaiopolis Campus, 41500 Larisa, Greece

Funding

Hellenic Foundation for Research and Innovation

References (47)

Show source-provided references
1. WHO (2026, February 05). W.H.O. Cardiovascular diseases (CVDs). Available online: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-%28cvds%29.
2. British Heart Foundation (2026, May 03). Global Cardiovascular Disease Factsheet. Available online: https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-cvd-statistics-global-factsheet-jan26.pdf.
3. Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators (2025). Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990–2023. J. Am. Coll. Cardiol., 86, 2167–2243.
4. Global burden of cardiovascular diseases: Projections from 2025 to 205010.1093/eurjpc/zwae281 ↗
5. The polypill in the primary prevention of cardiovascular disease: Cost-effectiveness in the Dutch population10.1136/bmjopen-2011-000363 ↗
6. 10-year resource utilization and costs for cardiovascular care10.1016/j.jacc.2017.12.064 ↗
7. Framingham risk score and prediction of lifetime risk for coronary heart disease10.1016/j.amjcard.2004.03.023 ↗
8. European Society of Cardiology (2026, May 03). SCORE2 and SCORE2-OP. Available online: https://www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/SCORE-Risk-Charts#.
9. American College of Cardiology (2026, May 03). ASCVD Risk Estimator. Available online: https://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/.
10. Machine-learning versus traditional approaches for atherosclerotic cardiovascular risk prognostication in primary prevention cohorts: A systematic review and meta-analysis
11. Samaras, A.D., Feleki, A., Apostolopoulos, I.D., Moustakidis, S., Papageorgiou, E., Kokkinos, K., and Papandrianos, N. (2024). Medical Decision Support System in Nuclear Medicine Diagnosis for Non-Small Cell Lung Cancer and Coronary Artery Disease: A First Stage Prototype. 2024 15th International Conference on Information, Intelligence, Systems & Applications (IISA), IEEE.10.1109/IISA62523.2024.10786612 ↗
12. The virtual doctor: An interactive clinical-decision-support system based on deep learning for non-invasive prediction of diabetes10.1016/j.artmed.2019.101706 ↗
13. Machine learning-based coronary artery disease diagnosis: A comprehensive review10.1016/j.compbiomed.2019.103346 ↗
14. Yu, Y., Peng, C., Zhang, Z., Shen, K., Zhang, Y., Xiao, J., Xi, W., Wang, P., Rao, J., and Jin, Z. (2022). Machine learning methods for predicting long-term mortality in patients after cardiac surgery. Front. Cardiovasc. Med., 9.10.3389/fcvm.2022.831390 ↗
15. Deep learning for prediction of obstructive disease from fast myocardial perfusion SPECT: A multicenter study10.1016/j.jcmg.2018.01.020 ↗
16. Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: A 5-year multicentre prospective registry analysis
17. Cardiovascular event prediction by machine learning: The multi-ethnic study of atherosclerosis10.1161/CIRCRESAHA.117.311312 ↗
18. A systematic review of machine learning in heart disease prediction10.55730/1300-0152.2766 ↗
19. Alaa, A.M. (2019). Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants. PLoS ONE, 14.10.1371/journal.pone.0213653 ↗
20. Machine learning in cardiovascular risk prediction and precision preventive approaches10.1007/s11883-023-01174-3 ↗
21. AI in medicine must be explainable10.1038/s41591-021-01461-z ↗
22. Translation of predictive modeling and AI into clinics: A question of trust10.1007/s00330-021-07977-9 ↗
23. AI-assisted decision-making in healthcare: The application of an ethics framework for big data in health and research10.1007/s41649-019-00096-0 ↗
24. Trust, regulation, and human-in-the-loop AI: Within the European region10.1145/3511597 ↗
25. Classification models for assessing coronary artery disease instances using clinical and biometric data: An explainable man-in-the-loop approach10.1038/s41598-023-33500-9 ↗
26. Coronary risk associated with age and sex of parental heart disease in the Framingham Study10.1016/0002-9149(89)90477-3 ↗
27. Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults10.1016/S0002-9149(01)01548-X ↗
28. World Health Organization (2022, October 13). A Healthy Lifestyle—WHO Recommendations. Available online: https://www.who.int/europe/news-room/fact-sheets/item/a-healthy-lifestyle---who-recommendations.
29. Prevalence and impact of high BMI in CAD patients10.1093/eurjpc/zwac056.179 ↗
30. Kim, J. (2022). Machine learning models of clinically relevant biomarkers for the prediction of stable obstructive coronary artery disease. Front. Cardiovasc. Med., 9.10.3389/fcvm.2022.933803 ↗
31. Teja, M.D., and Rayalu, G.M. (2025). Optimizing heart disease diagnosis with advanced machine learning models: A comparison of predictive performance. BMC Cardiovasc. Disord., 25.10.1186/s12872-025-04627-6 ↗
32. An explainable hybrid framework for early detection of cardiovascular diseases using Categorical Boosting and Bees algorithm10.1038/s41598-025-28514-4 ↗
33. Si, Y. (2025). Optimized feature selection and advanced machine learning for stroke risk prediction in revascularized coronary artery disease patients. BMC Med. Inform. Decis. Mak., 25.10.1186/s12911-025-03116-2 ↗
34. Tasmurzayev, N. (2025). Explainable AI for Coronary Artery Disease Stratification Using Routine Clinical Data. Algorithms, 18.10.3390/a18110693 ↗
35. A random forest guided tour10.1007/s11749-016-0481-7 ↗
36. Prokhorenkova, L. (2018). CatBoost: Unbiased boosting with categorical features. Advances in Neural Information Processing Systems, Curran Associates Inc.
37. Schapire, R.E. (2013). Explaining Adaboost, in Empirical Inference, Springer.10.1007/978-3-642-41136-6_5 ↗
38. Xgboost: Extreme gradient boosting
39. Hollmann, N. (2022). Tabpfn: A transformer that solves small tabular classification problems in a second. arXiv.
40. Guo, G., Wang, H., Bell, D., Bi, Y., and Greer, K. (2003). KNN model-based approach in classification. OTM Confederated International Conferences “On the Move to Meaningful Internet Systems”, Springer.10.1007/978-3-540-39964-3_62 ↗
41. Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences, Routledge.
43. Prevalence of conventional risk factors in patients with coronary heart disease10.1001/jama.290.7.898 ↗
44. Classical risk factors and emerging elements in the risk profile for coronary artery disease
45. Risk factors for coronary artery disease: Historical perspectives10.4103/HEARTVIEWS.HEARTVIEWS_106_17 ↗
46. Established risk factors and coronary artery disease: The Framingham Study10.1093/ajh/7.7.7S ↗
47. Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors10.1016/j.amjcard.2009.01.353 ↗